60-87-7

• 常用中文名：异丙嗪
• 常用英文名：Promethazine
• CAS号：60-87-7
• 分子式：C₁₇H₂₀N₂S
• 分子量：284.41900
• 相关类别： 原料药 激素及调节内分泌功能类药 前列腺素类药
• 发布时间：2018-07-25 21:25:38
• 更新时间：2026-08-02 13:40:26

名称

• 中文名: 异丙嗪
• 英文名: promethazine
• 中文别名: 异丙嗪相关杂质; 异丙嗪溶液,100PPM; 异丙美沙嗪; 菲那根; 异丙嗪溶液; 菲那根、异丙美沙嗪; 普鲁米近; 乙腈中异丙嗪标准溶液; 异丙嗪峰鉴别 标准品; 异丙嗪,10 MM DMSO 溶液
• 英文别名: Phenothiazine, 10-[2-(dimethylamino)propyl]- (8CI); Fenazil; Fargan; Hiberna; Prometasin; Prorex; 3389 R.P; Promethazine (base and/or unspecified salts); Lercigan; (RS)-dimethyl[1-methyl-2-(phenothiazone-10-yl)ethyl]amine hydrochloride; dimethyl-(1-methyl-2-phenothiazin-10-yl-ethyl)amine; N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine; A-91033; 10H-Phenothiazine-10-ethanamine, N,N,a-trimethyl- (9CI); Pilpophen; Promethaine; Dimethylamino-isopropyl-phenthiazin; Phgan; N-Dimethylamino-2-methylethyl thiodiphenylamine; Histgan; WY 509; Phenothiazine, 10-[2-(dimethylamino)propyl]; Avomine; 10-(2-DIMETHYLAMINOPROPYL)-PHENOTHIAZIN; Phensedyl; 3277 RP; N,N-Dimethyl-1-(10H-phenothiazin-10-yl)-2-propanamine; NCI-C60673; Diphergan; PROMETHAZINE; 10-[2-(Dimethylamino)propyl]phenothiazine; Isophenergan; N,N-diMethyl-1-(10H-phenothiazin-10-yl)propan-2-aMine; N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine; (Dimethylamino-2-propyl-10-phenothiazine hydrochloride; 10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl; 10H-Phenothiazine-10-ethanaMine,N,N,a-triMethyl; Pipolphen; Dimapp; 10-(2-(Dimethylamino)-2-methylethyl)phenothiazine; (2-Dimethylamino-2-methyl)ethyl-N-dibenzopathiazine; N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine; Promazinamide; Fenetazina; Lergigan; Iergigan; Prometazin; Aprobit; N,N-dimethyl-1-phenothiazin-10-yl-propan-2-amine; 10-[2-(Dimethylamino)propyl]-10H-phenothiazine; Diprazine; Lilly; Phengan; 10-[2-(dimethylamino)propyl]phenothiazine; Procit; Diprozin; Proazaimine; 4182 R.P; Proazamine; Isopromethazine; Fgan

物化性质

• 密度: 1.131
• 沸点: 190-192ºC at 3 mm Hg
• 熔点: 60ºC
• 分子式: C₁₇H₂₀N₂S
• 分子量: 284.41900
• 精确质量: 284.13500
• PSA: 31.78000
• LogP: 4.30440
• 外观性状: 白色固体
• 折射率: 1.6000 (estimate)
• 储存条件: 室温，密闭，干燥

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : SO6825000 CHEMICAL NAME : Phenothiazine, 10-(2-dimethylaminopropyl)- CAS REGISTRY NUMBER : 60-87-7 BEILSTEIN REFERENCE NO. : 0088554 LAST UPDATED : 199707 DATA ITEMS CITED : 32 MOLECULAR FORMULA : C17-H20-N2-S MOLECULAR WEIGHT : 284.45 WISWESSER LINE NOTATION : T C666 BN ISJ B1Y1&N1&1 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : Standard Draize test ROUTE OF EXPOSURE : Administration into the eye SPECIES OBSERVED : Rodent - rabbit TYPE OF TEST : Rinsed with water ROUTE OF EXPOSURE : Administration into the eye SPECIES OBSERVED : Rodent - rabbit TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Administration onto the skin SPECIES OBSERVED : Human - child DOSE/DURATION : 13 mg/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation) Behavioral - wakefulness Behavioral - hallucinations, distorted perceptions TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Human - man DOSE/DURATION : 2857 ug/kg/C TOXIC EFFECTS : Behavioral - coma TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 140 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 700 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - muscle weakness Nutritional and Gross Metabolic - body temperature decrease TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 45 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 169 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 326 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 124 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 225 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 40 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 175 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 500 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Mammal - cat DOSE/DURATION : 250 mg/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation) Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 580 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 19 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 640 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 116 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 520 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 27 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 350 mg/kg SEX/DURATION : female 10-16 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - fetal death TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Parenteral DOSE : 350 mg/kg SEX/DURATION : female 4 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) MUTATION DATA TYPE OF TEST : Mutation in mammalian somatic cells TEST SYSTEM : Rodent - hamster Lung DOSE/DURATION : 10 mg/L REFERENCE : SHIGAZ Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- Volume(issue)/page/year: 70,943,1983 *** REVIEWS *** TOXICOLOGY REVIEW IDPYAK Industrial Pharmacology. (Mount Kisco, NY) V.1-3, 1974-79. Discontinued. Volume(issue)/page/year: 1,203,1974 TOXICOLOGY REVIEW ARVPAX Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. Volume(issue)/page/year: 5,447,1965 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M0709 No. of Facilities: 177 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 886 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M0709 No. of Facilities: 49 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 1726 (estimated) No. of Female Employees: 1010 (estimated)

安全

• 海关编码: 2934300000

合成路线

58-33-3 ~89% 60-87-7

文献：SOUTHWEST RESEARCH INSTITUTE Patent: WO2003/105811 A2, 2003 ; Location in patent: Page 26 ;

92-84-2 17256-39-2 ~70% 60-87-7

文献：Galons; Miocque; Combet-Farnoux; et al. Chemical and Pharmaceutical Bulletin, 1985 , vol. 33, # 11 p. 5108 - 5109

92-84-2 53309-35-6 ~% 60-87-7

文献：Journal of the American Chemical Society, , vol. 82, p. 1600 - 1607

60-87-7 ~% 7640-51-9 60-87-7

文献：Transition Metal Chemistry, , vol. 36, # 7 p. 767 - 774

92-84-2 108-14-5 ~% 60-87-7

文献：Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, , vol. 225, p. 306 US2607773 , ;

38878-40-9 ~% 60-87-7

文献：Journal of Physical Chemistry, , vol. 88, # 23 p. 5665 - 5669

92-84-2 108-14-5 ~% 303-14-0 60-87-7

文献：DE828103 , ; DRP/DRBP Org.Chem. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, , vol. 232, p. 415

72332-06-0 ~% 92-84-2 303-14-0 60-87-7

文献：Journal of Organic Chemistry, , vol. 45, # 4 p. 744 - 746

上下游产品

上游产品  8
58-33-3 92-84-2 17256-39-2 53309-35-6
60-87-7 108-14-5 38878-40-9 72332-06-0
下游产品  4
7640-51-9 60-87-7 581-30-6 38076-67-4

海关

海关编码	2934300000
中文概述	2934300000. 含一个吩噻嗪环系的化合物(吩噻嗪环系不论是否氢化,化合物未经进一步稠合的 ). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2934300000. other compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%